Abstract
Genetic variants have been associated with multiple traits through genome-wide association studies (GWASs), but pinpointing causal variants and their mechanisms remains challenging. Molecular phenotypes, such as eQTLs, are routinely used to interpret GWAS results. However, much concern has recently been raised about their weak overlap. Taking the opposite approach with PRISM (Pleiotropic Relationships to Infer the SNP Model), we leverage pleiotropy to pinpoint direct effects and build variant causal networks. PRISM clusters variant-trait effects into trait-mediated, confounder-mediated, and direct effects, and builds individual variant causal networks by cross-referencing results from all traits. In simulations, PRISM demonstrated high precision in identifying direct effects and reconstructing causal networks. Applying PRISM to 61 traits and diseases from UK Biobank, we found that direct effects accounted for less than 13% of significant effects, yet were highly enriched in heritability. Multiple lines of evidence showed that PRISM causal networks are consistent with established biological mechanisms.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
MT, AN, and MV are supported by the French National Research Agency (ANR) (ANR-21-CE45-0023-01). MT and MFM are supported by the data intelligence institute of Paris (diiP, IdEx Universite Paris Cite, ANR-18-IDEX-0001). MT is a PhD student from the FIRE PhD program funded by the Bettencourt Schueller foundation and the EURIP graduate program (ANR-17-EURE-0012).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used only openly available human data in the form of summary statistics from the UK Biobank.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
This revision incorporates additional results from both simulations and the real application. Several figures and sections of the text have been revised for improved clarity. Additionally, the complete results are now available for download.
Data Availability
PRISM is implemented in R and a user-friendly tutorial is available on github. PRISM results are available on Zenodo or easily accessible through an online user-friendly ShinyR interface. Results can be visualized at the trait level and also to display the causal network of any genetic variant of interest.